FDA issued a Warning Letter to Dongying Tiandong Pharmaceutical Co Ltd on 11/10/2016 for a previous inspection.
483 Dongying Tiandong Pharmaceutical Oct 2018

483 Dongying Tiandong Pharmaceutical Oct 2018

Marijo Kambere FDA$119.00 - Available Now

FDA investigators audited the Dongying Tiandong Pharmaceutical - Dongying, China facility and issued inspectional observations (via FDA 483) on 19 Oct 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 19 Oct 2018
  • Location: Dongying, China
  • FEI: 3004395180
Add To Cart